Pdl Biopharma Inc (PDLI)

Operating Cash Flow (Statement)

$13.17M

TTM · Period ending: · USD

PDLI logo

PDLI Operating Cash Flow (Statement)

Latest reported$13.17M
PDLI TTM Cash from Operations (-$7.60M → $13.17M)
High-resolution chart · PNG

PDLI operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pdl Biopharma Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
13,173,000
-56,351,000
-55,977,000
-32,443,000
-15,365,000
-1,844,000
4,611,000
-13,425,000
-28,798,000
-40,744,000
-18,679,000
40,624,000
73,716,000
68,578,000
54,994,000
101,718,000
156,144,000
240,317,000
322,125,000
301,465,000
300,428,000
302,028,000
272,348,000
292,281,000
284,449,000
253,189,000
308,669,000
270,890,000
261,274,000
251,277,000
246,320,000
210,216,000
203,768,000
204,652,000
200,830,000
169,782,000
154,623,000
148,596,000
144,212,000
184,300,000
208,463,000
207,208,000
186,177,000
186,954,000
121,107,000
176,008,000
137,193,000
80,149,000
117,095,000
28,593,000
46,758,000
66,973,000
44,628,000
81,525,000
67,381,000
78,770,000
78,198,000
77,113,000
42,422,000
31,550,000
13,602,000
-14,069,000
-29,646,000
-27,156,000
-27,102,000
-48,688,000
-35,677,000
-22,965,000
-12,623,000
-744,000
658,000
-5,071,000
654,000
5,209,000
4,697,000
2,588,000
9,175,000
-3,621,000
3,067,000
6,827,000
-8,665,000
4,312,000
-6,575,000
-11,000,000
-3,500,000
-3,200,000
-6,600,000
-6,500,000
-5,500,000
-5,900,000
-5,300,000
-7,600,000
-7,600,000
-9,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.